Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care?

Join 3 experts in discussion about the potential role of dual incretin agonist peptides in patients with type 2 diabetes. Credit available for this activity expires: 12/20/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/964951?src=mkm_podcast_addon_964951